Main container

De Feo Alessandra, PhD

CV

Date of Birth
30/05/1987
Qualification

PhD

Current assignment

Biotechnologist

Title of qualification awarded
  • 2017: PhD in Experimental Medicine (School of Biology and Molecular Medicine), at the University “Sapienza”, Rome.
  • 2012: MSc in Medical Biotechnology (LM-9), at the University “Sapienza”, Rome, with honors.
Other qualifications awarded

2014: Qualification as Biologist, University “Tor Vergata”, Rome.

Positions held
  • From 2020: Biotechnologist. Research activity: IGF2BP3 as novel biomarker of Ewing sarcoma progression, at the Laboratory of Experimental Oncology, Rizzoli Orthpaedic Institute
  • 2018-20: Post-doctoral fellowship. Research activity: study of roles of d exosomes in Ewing's sarcoma at the Laboratory of Experimental Oncology, Rizzoli Orthpaedic Institute
  • 2017-18: AIRC two-year fellowship. Research activity: the possible antitumorigenic roles of miR-34a and sh-CD99 enriched exosomes in Ewing's sarcoma at the Laboratory of Experimental Oncology, Rizzoli Orthpaedic Institute
  • 2013-16:  Fellowship. Research activity: biological and molecular aspects of melanoma and sarcoma, focusing on the functional role of exosomes in cancer, at the department of Hematology, Oncology and Molecular Medicine, High Institute of Health, Rome
  • 2013: Graduated in Molecular Oncology at the Department of Hematology, Oncology and Molecular Medicine, High Institute of Health, Rome. Work activity: biological and molecular aspects of melanoma.
Languages

English, French.

Technologies

During the apprenticeship a number of techniques were learned and applied (immunofluorescence; Western blotting; RNA, DNA and proteins extraction; cloning of cDNA fragments and extraction with analyses of exosomes). In completion of a specialized master degree and a PhD, a good level of expertise in analyzing protein expression in both cell lysate and conditioned medium, as well as in nanovesicles released by cells, has been developed. A good level of expertise has been developed in studying biochemical pathways that control tumorigenesis of Melanoma and Sarcoma cells, by using real time PCR, culture of adherent cell lines, Western blot, immunofluorescence and gene silencing experiments. Additionally, a working knowledge of computational programs has been attained.

Scientific activities
  • November 6th-8th, 2019: 1st EVita Symposium 2019, Palermo, Italy.
  • November 27th-28th, 2018: 31st Annual Conference of the Italian Association of Cell Cultures (AICC), Bologna.
  • April 14th-18th, 2018: AACR (American Association for Cancer Research) Annual Meeting 2018, Chicago, USA.
  • November 27th-28th, 2017: AICC Annual Meeting 2017 (Italian Association of cell Cultures), Milan.
  • September 20th-23rd, 2017: ABCD National Congress 2017 (Italian Association of Cell Biology and Differentiation), Bologna.
  • March 27th-31st, 2017: 9th Joint IOR/MSKCC/HSS XXX Course on Musculoskeletal Pathology, Bologna, Italy.
  • September 5th-8th, 2016: 58th Annual Meeting of SIC (Italian Cancer Society), Verona, Italy.
  • June 9th-10th, 2016: AICC meeting – Exosomes in Pathological Conditions: new insights for biomarker development and therapeutic application, Rome.
  • June 20th-23rd, 2015: 57th Annual Meeting of SIC (Italian Cancer Society), Florence.
  • September 11th-13th, 2014: 56th Annual Meeting of SIC (Italian Cancer Society), Ferrara, Italy.
Clinical and/or Scientific interests

Identification of proteins and microRNAs contained in exosomes released by tumor cells. In charge of studies aimed at clarifying the role of circulating IGF2BP3 in Ewing's sarcoma.